Exact Mass: 306.0368

Exact Mass Matches: 306.0368

Found 16 metabolites which its exact mass value is equals to given mass value 306.0368, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoate

2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid

C14H10O8 (306.0376)


2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoate is part of the Flavonoid metabolism pathway. It is a substrate for: Pirin.

   

Methyl brevifolin carboxylate

Methyl brevifolin carboxylate

C14H10O8 (306.0376)


   

Methyl brevifolincarboxylate

Methyl 7,8,9-trihydroxy-3,5-dioxo-1,2,3,5-tetrahydrobenzo[d]cyclopenta[b]pyran-1-carboxylate

C14H10O8 (306.0376)


Methyl brevifolincarboxylate is an organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity. It has a role as a metabolite, a vasodilator agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a radical scavenger and a platelet aggregation inhibitor. It is an organic heterotricyclic compound, a delta-lactone, a member of phenols and a cyclic ketone. Methyl brevifolincarboxylate is a natural product found in Euphorbia maculata and Phyllanthus niruri with data available. An organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity.

   
   

Phyllanthusiin E methyl ester

Phyllanthusiin E methyl ester

C14H10O8 (306.0376)


   

6-Bromo-2-cyclohexylquinazolin-4(3H)-one

6-Bromo-2-cyclohexylquinazolin-4(3H)-one

C14H15BrN2O (306.0368)


   

4-(METHYLSULPHONYL)ANILINE

4-(METHYLSULPHONYL)ANILINE

C14H15BrN2O (306.0368)


   

2-(3-Bromophenyl)-5-cyclohexyl-1,3,4-oxadiazole

2-(3-Bromophenyl)-5-cyclohexyl-1,3,4-oxadiazole

C14H15BrN2O (306.0368)


   

3-(4-Bromophenyl)-5-cyclohexyl-1,2,4-oxadiazole

3-(4-Bromophenyl)-5-cyclohexyl-1,2,4-oxadiazole

C14H15BrN2O (306.0368)


   

5,5,6,6-Tetrahydroxybiphenyl-3,3-dicarboxylic acid

5,5,6,6-Tetrahydroxybiphenyl-3,3-dicarboxylic acid

C14H10O8 (306.0376)


   

(NZ)-N-(6-bromo-9-ethyl-3,4-dihydro-2H-carbazol-1-ylidene)hydroxylamine

(NZ)-N-(6-bromo-9-ethyl-3,4-dihydro-2H-carbazol-1-ylidene)hydroxylamine

C14H15BrN2O (306.0368)


   

2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid

2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid

C14H10O8 (306.0376)


   

(z)-3',5,5',6'-tetrahydroxy-4,4'-dimethyl-[1,1'-bi(cyclohexylidene)]-3',4,5'-triene-2,2',3,6-tetrone

(z)-3',5,5',6'-tetrahydroxy-4,4'-dimethyl-[1,1'-bi(cyclohexylidene)]-3',4,5'-triene-2,2',3,6-tetrone

C14H10O8 (306.0376)


   

1,7,8-trihydroxy-3-methyl-10-oxo-1h-pyrano[4,3-b]chromene-9-carboxylic acid

1,7,8-trihydroxy-3-methyl-10-oxo-1h-pyrano[4,3-b]chromene-9-carboxylic acid

C14H10O8 (306.0376)


   

methyl (1r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-1-carboxylate

methyl (1r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-1-carboxylate

C14H10O8 (306.0376)


   

methyl 2-{11,12-dihydroxy-3,8-dioxo-2,7-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,9(13),10-tetraen-4-yl}acetate

methyl 2-{11,12-dihydroxy-3,8-dioxo-2,7-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,9(13),10-tetraen-4-yl}acetate

C14H10O8 (306.0376)